EXCELLENT NEWS FOR ENTB/ZANDER. Accumulate and Hold imo.GLTA To our great excitement, we believe we are only three or four months away from having an optimized activator in hand, which we can then test in several animal models of autoimmunity. Similarly, we also expect to have an optimized inhibitor a few months afterward (in calendar Q1 of 2018), which we can then test it in several animal models of cancer.
The exponential development continues month by month to produce drugs for cancer and autoimmune diseases. Very nice summation by Lander. Good to hear there is interest now already and that shareholder value is a key concern. So wait for $$$. The news gets bigger and more important as time goes on here and if it tracks as expected that won't be much longer. All IMO. GL.